Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Blueprint Health
AddedFeb 15, 2024
UpdatedJun 28, 2026
Blueprint Health

Blueprint Health

Operating

Blueprint Health: A NYC-based healthtech accelerator, fostering innovation with mentorship, capital, and a vibrant community.

Location
New York City, NY, US
Founded
2011
Firm
Compare
Portfolio
Employees
Website

Blueprint Health is a NYC-based healthtech accelerator focused on supporting early-stage startups at the intersection of health and technology. The firm typically invests in seed and pre-seed rounds, with occasional Series A and B investments. Blueprint Health offers an intensive three-month program that provides startups with access to capital, clients, and a robust mentor community. The program aims to help companies gain customers, raise capital, build marketing and sales collateral, and refine their investor pitches.

Notable portfolio companies include AdhereTech, Docasap, and Keona Health. Key partners and mentors at Blueprint Health bring extensive experience from leading healthcare and technology firms. The accelerator's investment philosophy centers on fostering innovation through mentorship and community support. Blueprint Health also offers continued assistance to alumni founders beyond the initial program, ensuring long-term growth and success. Their 12,000 sq ft Loft in SoHo serves as a vibrant hub for over 40 health tech startups, strategics, and funders.

Blueprint Health - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments61
Current Portfolio Count50
Total Portfolio Exits2

Top Investment Stages

Seed52 (85.2%)
Pre-Seed5 (8.2%)
Series A2 (3.3%)
Series B1 (1.6%)
Series Unknown1 (1.6%)

Stage Mix

Seed 85%Pre-Seed 8%Series A 3%Series B 2%Series Unknown 2%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Pathology Watch logo

Pathology Watch

HealthKick logo

HealthKick

Truevation logo

Truevation

TweeQ logo

TweeQ

Sparkite logo

Sparkite

ThriveStreams logo

ThriveStreams

SimplifiMed logo

SimplifiMed

MediQuire logo

MediQuire

NexHealth logo

NexHealth

Psocratic logo

Psocratic

DocDelta logo

DocDelta

Position Health logo

Position Health

Hipaafix logo

Hipaafix

Crediyo logo

Crediyo

Oculus Health logo

Oculus Health

Healthy Bytes logo

Healthy Bytes

GlucoIQ logo

GlucoIQ

GroupHub logo

GroupHub

TapGenes logo

TapGenes

Moving Analytics logo

Moving Analytics

Nurep logo

Nurep

Medikly logo

Medikly

Parable Health logo

Parable Health

Stirplate logo

Stirplate

OhMD logo

OhMD

Blueprint Health - Classification

Also Known As
  • Blueprint Health LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 7300Business Services
Show 6 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified